1. Home
  2. WRBY vs AMPH Comparison

WRBY vs AMPH Comparison

Compare WRBY & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$26.33

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.81

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
AMPH
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.2B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
WRBY
AMPH
Price
$26.33
$26.81
Analyst Decision
Buy
Buy
Analyst Count
15
6
Target Price
$25.43
$31.00
AVG Volume (30 Days)
5.7M
399.3K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
2.27
Revenue
$850,580,000.00
$723,305,000.00
Revenue This Year
$15.47
$1.35
Revenue Next Year
$13.06
$5.10
P/E Ratio
$10,382.29
$11.66
Revenue Growth
14.55
N/A
52 Week Low
$13.63
$20.39
52 Week High
$31.00
$39.77

Technical Indicators

Market Signals
Indicator
WRBY
AMPH
Relative Strength Index (RSI) 62.21 53.61
Support Level $25.71 $26.26
Resistance Level $27.29 $27.44
Average True Range (ATR) 2.06 0.83
MACD 0.09 0.04
Stochastic Oscillator 64.54 71.43

Price Performance

Historical Comparison
WRBY
AMPH

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: